Abstract P144: Covid-19 And The Use Of Angiotensin-converting Enzyme Inhibitors And Receptor Blockers. Real World Experience.

Baher Al Abbasi,Nakeya Dewaswala,Fergie Ramos,Ahmed Abdallah,Pedro Torres,Kai Chen,Mohamed Abdul Qader,Samar Aboulenain,Karolina N. Dziadkowiec,Jesus Pino,Robert Chait

Abstract P144: Covid-19 And The Use Of Angiotensin-converting Enzyme Inhibitors And Receptor Blockers. Real World Experience.

2020

Baher Al Abbasi
Nakeya Dewaswala
Fergie Ramos
Ahmed Abdallah
Pedro Torres
Kai Chen
Mohamed Abdul Qader
Samar Aboulenain
Karolina N. Dziadkowiec
Jesus Pino
Robert Chait

Background: Concerns exist that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) increase susceptibility to coronavirus SARS CoV-2 (the virus that causes the...

Keywords:

Severe Acute Respiratory Syndrome Coronavirus
Receptor
Angiotensin-converting enzyme
Coronavirus disease 2019
Virus
Pharmacology
Angiotensin Receptor Blockers
Enzyme
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations